SEP 19, 2017 09:17 AM PDT

Bacteria contribute to chemotherapy resistance

WRITTEN BY: Kerry Evans

Bacteria in tumors make cancer resistant to chemotherapy. Wait, what? That’s right. According to Ravid Straussman at the Weizmann Institute, Gammaproteobacteria inside of pancreatic tumors metabolize the chemotherapy drug gemcitabine into its inactive form. Gemcitabine is a nucleoside analog that is commonly used to treat pancreatic cancer, as well as breast, bladder, and lung cancers.

 

Bacteria can make tumors resistant to chemotherapy

Image: Mesothelioma Clinic

Hold up - bacteria in tumors? Yes, evidently that’s a thing, and I’ll take their word for it (for now). Initially, Straussman and his colleagues observed that conditioned medium from human dermal fibroblasts made colorectal and pancreatic cancer cells resistant to gemcitabine. When they filtered the medium, however, it no longer conferred resistance. Thus, they hypothesized that something bacteria-sized made the cancer cells resistant to gemcitabine.

They sequenced the conditioned medium and found DNA from Mycoplasma (mostly Mycoplasma hyorhinis). Further, when they treated the medium with an antibiotic, it no longer made cancer cells resistant to gemcitabine. One possibility was that gemcitabine was being modified in some way. Thus, they used high-performance liquid chromatography-tandem mass spectrometry to show that, indeed, the bacteria metabolized gemcitabine into its inactive form. Notably, Mycoplasma isn’t the only bacterium that can modify gemcitabine; 13 of 27 other species they tested did so as well.

Next, they wanted to know wanted to know which Mycoplasma genes were required to metabolize gemcitabine. Actually, they knew that the bacterial enzyme cytidine deaminase (CDD) was able to modify gemcitabine, so they investigated this gene first. Of the 27 bacterial species they tested previously, all of the ones that expressed the long form of CDD (CDDL) conferred gemcitabine resistance. None of the species that lacked CDD conferred resistance, but one that expressed the short form of CDD did.

To confirm that CDDL conferred gemcitabine resistance, they deleted CDDL from E. coli and showed that these bacteria could not metabolize gemcitabine. As expected, restoring CDDL activity to E. coli also restored the ability to metabolize gemcitabine.

Finally, the researchers validated their findings in an animal model. They injected colon tumor-bearing mice with a strain of E. coli that colonizes tumors and produces CDDL. They also tagged the bacteria and tumor cells with different fluorescent tags, allowing them to image each cell type in vivo. Then, they treated mice with gemcitabine with or without an antibiotic to kill the CDDL-producing E. coli. Bacteria were not detected in the antibiotic-treated mice, and these mice showed an antitumor response with gemcitabine. In the mice that weren’t treated with antibiotics, however, gemcitabine had no effect on tumor growth.

Sources: Science and Weizmann Institute

 

About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
NOV 17, 2019
Health & Medicine
NOV 17, 2019
Honey As An Antibacterial Against Methicillin-Resistant Staphylococcus Aureus
Honey has been used for its medicinal properties for thousands of years to treat wound infections, gastrointestinal ailments, and burns. Because of th...
NOV 17, 2019
Microbiology
NOV 17, 2019
Drug-Resistant Microbes Found in Many Raw Pet Foods
Raw dog food is marketed as a diet that mimics the food of dog's ancestors. But it may pose a serious risk to both pets and their human companions....
NOV 17, 2019
Immunology
NOV 17, 2019
Immune System Responsible for Organ Failure in Malaria
In the most severe cases of malaria, a person can experience organ failure and die. Often times, though, this is not directly due to the parasitic malaria ...
NOV 17, 2019
Immunology
NOV 17, 2019
Algorithm Predicts Response to HIV Immunotherapy
Blood samples from HIV patients produced the data necessary for two scientists to build a mathematical model for predicting how HIV patients will respond t...
NOV 17, 2019
Microbiology
NOV 17, 2019
Probiotics Linked to Bloodstream Infections in ICU Patients
Probiotics, which are live microbes, are intended to improve human health, and they are sometimes given to intensive care unit patients of all ages....
NOV 17, 2019
Cancer
NOV 17, 2019
Understanding H. pylori and gastric cancer
New research published in the journal Gastroenterology offers insight on gastric cancer and the presence of the common bacteria known as H. pylori (Helicob...
Loading Comments...